Sigilon Revenue and Competitors

Boston, MA USA

Location

$263.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sigilon's estimated annual revenue is currently $11.4M per year.(i)
  • Sigilon's estimated revenue per employee is $153,649
  • Sigilon's total funding is $263.2M.
  • Sigilon's current valuation is $68.5M. (January 2022)

Employee Data

  • Sigilon has 74 Employees.(i)
  • Sigilon grew their employee count by -24% last year.

Sigilon's People

NameTitleEmail/Phone
1
VP, IMDReveal Email/Phone
2
VP, Intellectual Property CounselReveal Email/Phone
3
Head Supply ChainReveal Email/Phone
4
VP, Islet Cell Therapy ResearchReveal Email/Phone
5
VP, Head Bioanalytical & CMC Analytical DevelopmentReveal Email/Phone
6
Chief Business OfficerReveal Email/Phone
7
Associate Director, CMC Analytical DevelopmentReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Chief Legal and Admin OfficerReveal Email/Phone
10
Director, Preclinical & CMC Project Management OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Sigilon?

Harnessing the full power of cell therapeutics. Cambridge, MA

keywords:N/A

$263.2M

Total Funding

74

Number of Employees

$11.4M

Revenue (est)

-24%

Employee Growth %

$68.5M

Valuation

N/A

Accelerator

Sigilon News

2022-04-17 - Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus ...

Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus Rating of “Buy” by Brokerages. Posted by admin on Apr 22nd, 2022.

2022-03-30 - How Will the Market React to Sigilon Therapeutics Inc (SGTX) Stock Getting a Bullish Rating

The market has been high on Sigilon Therapeutics Inc (SGTX) stock recently. SGTX gets a Bullish score from InvestorsObserver Stock Sentiment...

2022-03-22 - Sigilon Therapeutics Reports Fourth Quarter and Full Year ...

Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of chronic diseases by harnessing the power of the human...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M74-14%N/A
#2
$13.7M7412%N/A
#3
$7.5M740%N/A
#4
$7.5M75-5%N/A
#5
$9.5M757%N/A